Cadila Healthcare gets Warning Letter from USFDA

Capital Market

Last Updated : Dec 31 2015 | 12:47 PM IST

For its Moraiya formulation facility and Ahmedabad API facility (Zyfine)

Cadila Healthcare has received a Warning Letter issued by the US FDA relating to its Moraiya formulation facility and Ahmedabad API facility (Zyfine).

Powered by Capital Market - Live News

More From This Section

TTK Prestige to hold board meeting

Everest Industries to hold board meeting

HT Media to hold board meeting

Pipavav Defence & Offshore Engg. Co. to hold board meeting

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Dec 31 2015 | 10:22 AM IST

Explore News

Stock Market LIVE Updates Stocks to Watch Today Shadowfax Technologies IPO Cipla Q3 Results Q3 Result Today Why Market is Falling Delhi AQI Today Budget Week Market Outlook Budget 2026 Stock Market Holiday